Cent Eur J Public Health 2004, 12(2):91-93

The Background of beta-Oxidation Disorders in Humans. II. Laboratory Studies and Clinical data

Kuryl T.1, Debski B.1, Lipko M.1, Martinik K.2
1 Faculty of Veterinary Medicine, Division of Animal Biochemistry, Agricultural University, Warsaw, Poland
2 Pedagogical Faculty, Hradec Králové University, Hradec Králové, Czech Republic

Laboratory method for studies of clinical disorders of β-oxidation is described. The effects of other diet components such as microelements (Cr3+ ions) and non-digestible oligofructans (inulin and oligofructose) as stimulatory factors on the activity of β-oxidation and cholesterol and triacylglyceroles levels lowering are reported.

Keywords: energy production, β-oxidation, chromium ions, human, rats, broilers, laboratory method

Received: September 23, 2003; Revised: February 4, 2004; Accepted: February 4, 2004; Published: June 1, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuryl T, Debski B, Lipko M, Martinik K. The Background of beta-Oxidation Disorders in Humans. II. Laboratory Studies and Clinical data. Cent Eur J Public Health. 2004;12(2):91-93. PubMed PMID: 15242027.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Quintana PL, Crespo SP: Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders.An Esp Pediatr 2001; 55(6): 524-534. Go to PubMed...
    2. Eaton S, Barlett K, Pourfarzam M: Mammalian mitochondrial β-oxidation. Biochem J 1996; 320: 345-347. Go to original source... Go to PubMed...
    3. Murphy MSR, Kammana VS, Pande SV: A carnitine/acylcarnitine translocase assay applicable to biopsied specimens without requirement mitochondrial isolation. Biochem J 1986; 236: 143-148. Go to original source... Go to PubMed...
    4. Pande SV, Brivet M, SlamaA, Demangre F,Autrant CH, Sandubray J-M: Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. J Clin Invest 1993; 91: 1247-1252. Go to original source... Go to PubMed...
    5. Rasmussen UF, Krustrup P, Bangsbo J, Rasmussen HN: The effect of high-intensity exhaustive exercise studies in isolated mitochondria from human skeletal muscle. Pflugers Arch 2001; 443(2): 180-187. Go to original source... Go to PubMed...
    6. Kuryl T,Adamowicz M, Dębski B, Bertrandt J, Martinik K: Degradation of [9,10-<sup>3</sup>H] myristic acid by lymphocyte. Screening test of inherited disorders of activation, transport and mitochondrial oxidation of fatty acids. Atherosclerosa 2001; 23: 23-26.
    7. Manning NJ, Olpin SE, Pollitt RJ, Webley J: A comparison of [9,10-<sup>3</sup>H] palmitic acid and [9,10-<sup>3</sup>H] myristic acid from the detection of defects of fatty acids oxidation in intact cultured fibroblasts. J Inher Metab Dis 1990; 13: 58-68. Go to original source... Go to PubMed...
    8. Horowitz JF: Regulation of lipid mobilization and oxidation during exercise in obesity. Exerc Sport Sci Rev 2001; 29(1): 42-46. Go to original source... Go to PubMed...
    9. Lipko M, Kuryl T, Dębski B: Mechanism of insulin-like effect of chromium ions on glucose uptake by C2C12 mouse myotubes. University of Hradec Králové, Pedagogical Faculty, 2002; IX, pp. 348-349.
    10. Lipko M, OrzechowskiA, Kuryl T, Dębski B: Influence of chromium on glucose uptake in mouse myotubes. Mengen- und Spurenelemente, 21 Arbeistagung 2002, Friedrich Schiller-Universität, Jena, Schubert Verlag, Leipzig, 2002; pp. 560-566.
    11. Anderson RA: Elevated intake of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes., Diabetes 1997; 46, 1786-1791. Go to original source... Go to PubMed...
    12. Anderson RA: Chromium in the prevention and control of diabetes. Diabetes Metab 2000; 26 (1), 22-27.
    13. Olpin SE, Manning NJ, Pollitt RJ, Bonham JR, Downing M, Clark S: The use of [9,10-<sup>3</sup>H] palmitate and [9,10-<sup>3</sup>H] oleate for detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. Adv Exp Med Biol 1999; 466: 321-325. Go to original source...
    14. Wanders RJA, Vraken M. EJ, Den Boer FA: Disorders of mitochondrial fatty acyl-CoA β-oxidation. J Inher Metab Dis 1999; 22: 442-487. Go to original source... Go to PubMed...
    15. Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PA: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 1988; 319: 1331-1336. Go to original source... Go to PubMed...
    16. Giros M, Ruiz M, Ribes A, Pampols T: The diagnosis of peroxisomal disorders in Spain during the period 1987 - 1997. Rev Neurol 1999; Suppl. 1:40-44.
    17. Wanders RJ, Vraken P, Ferdinandusse S, Jansen GA, Waterham HR, van Roermund CW, van Grunsven EG: Peroxisomal fatty acid α-and-β-oxidation in humans:enzymology, peroxisomal metabolite transporters and peroxisomal disease. Biochem Soc Trans 2001; 29(2): 250-267. Go to original source... Go to PubMed...
    18. Kuryl T, Lipko M, Dębski B: Metabolism of fatty acids in broiler chicken is affected by chromium. In: Khassanova L, Collery P, Maymard I, Khassanova Z, Etienne JC (eds), Metal ions in biology and medicine, John Libbey Eurotext, 2002: vol. 7, pp. 454-459.
    19. Pettegrew JW, Levine J, McClure RJ: Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiat 2000; 5(6): 616-632. Go to original source... Go to PubMed...
    20. Winter S, Birek L, Walker T, Phalin-Roque J, Chandler MJ, Field C, Zorn E: Therapy of metabolic disorders with intravenous (i.v.) access ports and long term intravenous L-carnitine therapy. Southeast Asian J Trop Med Publ Health 1999; 30:(Suppl. 2) 152-153.
    21. Debski B, Krynski A, Zalewski W, Kuryl T: Chromium-yeast influence on broilers in industrial farming system. Proc Int Soc Animal Hyg 2003; 2: 663-666.
    22. Letexier D, Diraison F, Beylot M:Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in human. Am J Clin Nutr 2003; 77(3): 559-564. Go to original source... Go to PubMed...
    23. Brighenti F, Casiraghi MC, Canzi E, Ferrari A: Effct of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur Clin Nutr 1999; 53(9): 726-733. Go to original source...
    24. Roberfroid MB, Cumps J, Devogelaer JP: Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr 2002; 132(12): 3599-3602. Go to original source... Go to PubMed...
    25. Ellegard L, Andersson H, Bosaeus I: Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, bile acids but increases energy excretion in the ileostomy subjects. Eur J Clin Nutr 1997; 5(1): 1-5. Go to original source...
    26. Kuryl T, Krejpcio Z, Wojciak R, Lipko M, Debski B: The influence of chromium and fructans enriched diet on β-oxidation activity of fatty acids in rat lymphocytes, Mengen- und Spurenelemente, Friedrich SchillerUniversität Jena 2003 (in press).

    Return to the content